The agent "Ambroxol" describes the instruction as a mucolytic drug. The medicine has an expectorant effect. The medication has the ability to stimulate serous cells in the glands of the bronchial mucosa, increases the amount of secretion, thus altering the disturbed balance of the mucous and serous component in sputum. Due to the effect of the agent, activation of hydrolyzing enzymes is noted. The drug is also able to slightly suppress cough. After application the product is absorbed from the digestive tract almost completely.
Approximately in 0,5-3 hours the maximum concentration of a drug is marked. The agent is able to quickly distribute the tissues in the body. The drug is found in milk, passes the BBB. The highest concentration of medication is seen in the lungs.
The "Ambroxol" medication is recommended for acute or chronic pathology of the respiratory tract, complicated by the formation of hard-to-separate sputum. In particular, the agent is indicated for bronchiectasis, bronchitis with obstructive syndrome, asthma. The drug is recommended for respiratory distress syndrome. The medication can be used from birth.
Rarely, the medication provokes vomiting, nausea, soreness in the abdomen, diarrhea. Against the background of hypersensitivity is probably the appearance of angioedema, hives, skin rashes. Other negative reactions of the body include headache, general weakness.
The agent "Ambroxol" instruction does not admit to prescription for ulcerative lesions of the gastrointestinal tract, convulsive syndrome of different nature. Not recommended for intolerance. Contraindications include the first trimester of the prenatal period.
Medication "Ambroxol". Instructions for use
Children under two years are prescribed twice a day for 7.5 mg, up to five - the same dose three times. From 5 to 12 years - 15 milligrams 2-3 r / d. Patients with 12 years of age are recommended to 30 mg twice or thrice a day. The drug "Ambroxol" (syrup for children) recommends the use of instructions in case of difficulty in swallowing tablets.
In the distress syndrome of the respiratory type, thoracic, including preterm infants, children are administered parenteral medication. Dosage in this case is calculated by the weight of the child. Intramuscularly or intravenously, 10 mg / kg / d is administered at a frequency of 3-4 r / day. In severe cases, dosage can be increased to 30 mg / kg / day. Treatment is carried out under the supervision of a doctor. The dosage of the inhalation means is set individually.
On the basis of bronchial asthma, to prevent the development of irritation in the respiratory tract before inhalation, bronchodilator agents are allowed. In the case of prescribing Ambroxol, nursing should resolve the issue of suspension of lactation. When using the drug in combination with antitussive medications, it is difficult to transport sputum. With the joint intake of "Doxycycline", "Amoxicillin" or "Cefuroxime" with medications, their penetration into the secret of the bronchi increases.